Poseida Therapeutics Inc. (PSTX) NASDAQ
$2.10 0.08 (3.96%)
Market Cap: $126.66M
As of 05/20/22 04:00 PM EDT. Market closed.
Poseida Therapeutics Inc. (PSTX) NASDAQ
$2.10 0.08 (3.96%)
Market Cap: $126.66M
As of 05/20/22 04:00 PM EDT. Market closed.
Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing its proprietary genetic engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. Poseida has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core proprietary platforms, including its ... read more
Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing its proprietary genetic engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. Poseida has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core proprietary platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ site-specific gene editing system and nanoparticle- and AAV-based gene delivery technologies. Its core platform technologies have utility, either alone or in combination, across many cell and gene therapeutic modalities and enable Poseida Therapeutics to engineer its wholly-owned portfolio of product candidates that are designed to overcome the primary limitations of current generation cell and gene therapeutics. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Eric Ostertag
Full Time Employees
206
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Eric Ostertag
Full Time Employees
206
URL
Address
9390 Towne Centre Drive, Suite 200, California, San Diego, 92121.
PRICE CHART
From:
To:
KEY STATS
Open
$2.16
Previous Close
$2.02
Days Range
$2 - $2.16
52 week range
$1.83 - $11.10
Volume
177,270
Avg. Volume (30 days)
267,547
Market Cap
$126.66M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
62,704,726
Open
$2.16
Previous Close
$2.02
Days Range
$2 - $2.16
52 week range
$1.83 - $11.10
Volume
177,270
Avg. Volume (30 days)
267,547
Market Cap
$126.66M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
62,704,726
Open in:
Open in:
INSIDER TRANSACTIONS FOR POSEIDA THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Ingalls Kerry D. | Chief Operating Officer | Mar 16, 2022 | Buy | $3.98 | 3,000 | 11,940 | 55,000 | Mar 18, 2022, 08:01 PM |
| Mylet Johanna | Chief Financial Officer | Dec 21, 2021 | Option Exercise | $1.59 | 5,716 | 9,061 | 34,231 | Dec 22, 2021, 04:53 PM |
| Spear Matthew A. | Chief Medical Officer | Dec 06, 2021 | Option Exercise | $1.32 | 10,000 | 13,220 | 61,485 | Dec 08, 2021, 08:38 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Dec 06, 2021 | Buy | $6.90 | 1,828 | 12,613 | 9,685,673 | Dec 07, 2021, 06:03 AM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Dec 02, 2021 | Buy | $6.88 | 4,296 | 29,550 | 9,683,845 | Dec 02, 2021, 06:33 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Dec 01, 2021 | Buy | $6.85 | 18,365 | 125,806 | 9,679,549 | Dec 02, 2021, 06:33 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 30, 2021 | Buy | $6.85 | 28,592 | 195,838 | 9,661,184 | Dec 02, 2021, 06:33 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 26, 2021 | Buy | $6.81 | 27,251 | 185,492 | 9,621,535 | Nov 29, 2021, 07:55 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 24, 2021 | Buy | $6.89 | 1,054 | 7,260 | 9,594,284 | Nov 29, 2021, 07:55 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 29, 2021 | Buy | $6.89 | 11,057 | 76,209 | 9,632,592 | Nov 29, 2021, 07:55 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 23, 2021 | Buy | $6.77 | 14,625 | 98,989 | 9,593,230 | Nov 23, 2021, 06:41 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 19, 2021 | Buy | $7.44 | 11,104 | 82,650 | 9,578,605 | Nov 23, 2021, 06:41 PM |
| Ostertag Eric | Chief Executive Officer | Nov 19, 2021 | Option Exercise | $9.15 | 1,000 | 9,150 | 697,422 | Nov 22, 2021, 07:50 PM |
| Ingalls Kerry D. | Chief Operating Officer | Nov 17, 2021 | Buy | $7.00 | 2,000 | 14,000 | 2,000 | Nov 18, 2021, 09:12 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 18, 2021 | Buy | $7.18 | 71,312 | 511,685 | 9,567,501 | Nov 18, 2021, 08:24 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 17, 2021 | Buy | $7.21 | 280,384 | 2,021,821 | 9,496,189 | Nov 18, 2021, 08:24 PM |
| Malin Life Sciences Holdings Ltd | 10% Owner | Nov 16, 2021 | Buy | $7.17 | 27,680 | 198,383 | 9,215,805 | Nov 18, 2021, 08:24 PM |
| Ostertag Eric | Chief Executive Officer | Nov 08, 2021 | Sale | $7.09 | 18,924 | 134,171 | 3,659,503 | Nov 10, 2021, 06:06 PM |
| Ostertag Eric | Chief Executive Officer | Oct 11, 2021 | Option Exercise | $9.15 | 18,525 | 169,504 | 696,422 | Oct 13, 2021, 06:59 PM |
| Ostertag Eric | Chief Executive Officer | Oct 01, 2021 | Sale | $7.02 | 20,029 | 140,604 | 3,669,376 | Oct 05, 2021, 06:16 PM |
| Ostertag Eric | Chief Executive Officer | Sep 20, 2021 | Sale | $8.00 | 20,000 | 160,020 | 160,696 | Sep 22, 2021, 05:51 PM |
| Ostertag Eric | Chief Executive Officer | Sep 13, 2021 | Option Exercise | $8.12 | 21,281 | 172,729 | 675,415 | Sep 15, 2021, 06:58 PM |
| Ostertag Eric | Chief Executive Officer | Sep 14, 2021 | Sale | $8.14 | 20,000 | 162,712 | 180,696 | Sep 15, 2021, 06:58 PM |
| Spear Matthew A. | Chief Medical Officer | Sep 09, 2021 | Option Exercise | $1.32 | 10,000 | 13,220 | 51,485 | Sep 10, 2021, 04:19 PM |
| Ostertag Eric | Chief Executive Officer | Sep 02, 2021 | Sale | $8.34 | 61,262 | 510,925 | 3,679,826 | Sep 03, 2021, 04:54 PM |
| Ostertag Eric | Chief Executive Officer | Sep 01, 2021 | Sale | $8.46 | 51,149 | 432,721 | 3,711,789 | Sep 03, 2021, 04:54 PM |
| Spear Matthew A. | Chief Medical Officer | Aug 20, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 45,485 | Aug 24, 2021, 05:12 PM |
| Spear Matthew A. | Chief Medical Officer | Aug 20, 2021 | Sale | $8.79 | 4,000 | 35,142 | 41,485 | Aug 24, 2021, 05:12 PM |
| Ostertag Eric | Chief Executive Officer | Aug 06, 2021 | Option Exercise | $9.15 | 111,149 | 1,017,013 | 654,134 | Aug 10, 2021, 06:56 PM |
| Ostertag Eric | Chief Executive Officer | Aug 03, 2021 | Sale | $7.99 | 19,936 | 159,289 | 3,738,475 | Aug 04, 2021, 04:57 PM |
| Ostertag Eric | Chief Executive Officer | Aug 02, 2021 | Sale | $8.13 | 13,737 | 111,682 | 3,748,876 | Aug 04, 2021, 04:57 PM |
| Spear Matthew A. | Chief Medical Officer | Jul 28, 2021 | Option Exercise | $1.32 | 20,000 | 26,440 | 41,485 | Jul 30, 2021, 04:29 PM |
| Ostertag Eric | Chief Executive Officer | Jul 02, 2021 | Sale | $8.91 | 27,542 | 245,274 | 3,770,309 | Jul 06, 2021, 05:35 PM |
| Ostertag Eric | Chief Executive Officer | Jul 01, 2021 | Sale | $9.77 | 20,563 | 200,901 | 3,770,413 | Jul 06, 2021, 05:35 PM |
| Spear Matthew A. | Chief Medical Officer | Jun 17, 2021 | Option Exercise | $1.32 | 5,000 | 6,610 | 21,485 | Jun 21, 2021, 08:02 PM |
| Spear Matthew A. | Chief Medical Officer | Jun 11, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 20,485 | Jun 14, 2021, 06:18 PM |
| Spear Matthew A. | Chief Medical Officer | Jun 11, 2021 | Sale | $9.44 | 4,000 | 37,747 | 16,485 | Jun 14, 2021, 06:18 PM |
| Ostertag Eric | Chief Executive Officer | Jun 02, 2021 | Sale | $8.34 | 40,722 | 339,621 | 3,781,142 | Jun 03, 2021, 07:21 PM |
| Ostertag Eric | Chief Executive Officer | Jun 01, 2021 | Sale | $8.61 | 41,194 | 354,680 | 3,802,388 | Jun 03, 2021, 07:21 PM |
| Ostertag Eric | Chief Executive Officer | May 03, 2021 | Sale | $9.01 | 18,326 | 165,117 | 3,842,656 | May 05, 2021, 07:29 PM |
| Ostertag Eric | Chief Executive Officer | May 04, 2021 | Sale | $8.44 | 35,986 | 303,722 | 3,823,881 | May 05, 2021, 07:29 PM |
| Spear Matthew A. | Chief Medical Officer | Apr 23, 2021 | Option Exercise | $1.32 | 5,000 | 6,610 | 16,485 | Apr 23, 2021, 08:49 PM |
| Spear Matthew A. | Chief Medical Officer | Apr 21, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 15,485 | Apr 23, 2021, 08:49 PM |
| Spear Matthew A. | Chief Medical Officer | Apr 21, 2021 | Sale | $8.44 | 4,000 | 33,752 | 11,485 | Apr 23, 2021, 08:49 PM |
| Ostertag Eric | Chief Executive Officer | Apr 01, 2021 | Sale | $9.55 | 57,181 | 546,330 | 3,882,383 | Apr 05, 2021, 07:50 PM |
| Ostertag Eric | Chief Executive Officer | Apr 05, 2021 | Sale | $9.66 | 57,819 | 558,668 | 3,853,834 | Apr 05, 2021, 07:50 PM |
| Ostertag Eric | Chief Executive Officer | Mar 02, 2021 | Sale | $11.54 | 57,060 | 658,415 | 3,912,217 | Mar 03, 2021, 07:38 PM |
| Ostertag Eric | Chief Executive Officer | Mar 01, 2021 | Sale | $11.67 | 57,940 | 676,046 | 3,942,515 | Mar 03, 2021, 07:38 PM |
| Ostertag Eric | Chief Executive Officer | Feb 23, 2021 | Option Exercise | $1.17 | 111,395 | 130,666 | 542,985 | Feb 25, 2021, 07:01 PM |
| Ostertag Eric | Chief Executive Officer | Feb 16, 2021 | Sale | $10.00 | 133,149 | 1,332,036 | 200,696 | Feb 17, 2021, 05:28 PM |
| Ostertag Eric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $1.29 | 67,534 | 87,119 | 431,590 | Feb 12, 2021, 05:03 PM |
| Ostertag Eric | Chief Executive Officer | Feb 10, 2021 | Sale | $10.00 | 12,389 | 123,890 | 333,845 | Feb 12, 2021, 05:03 PM |
| Ostertag Eric | Chief Executive Officer | Jan 21, 2021 | Sale | $10.00 | 4,462 | 44,620 | 346,234 | Jan 25, 2021, 07:42 PM |
| Mylet Johanna | Senior Vice President, Finance | Jan 15, 2021 | Option Exercise | $0.30 | 4,728 | 1,418 | 26,813 | Jan 19, 2021, 05:00 PM |
| Spear Matthew A. | Chief Medical Officer | Jan 15, 2021 | Option Exercise | $1.32 | 7,564 | 10,000 | 11,485 | Jan 19, 2021, 05:00 PM |
| Spear Matthew A. | Chief Medical Officer | Jan 08, 2021 | Option Exercise | $1.32 | 3,921 | 5,184 | 3,921 | Jan 11, 2021, 05:00 PM |
| Murphy Sean | Director | Jul 14, 2020 | Buy | $16.00 | 10,000 | 160,000 | 10,000 | Jul 15, 2020, 05:00 PM |
| Hirsch David | Director | Jul 14, 2020 | Buy | $16.00 | 250,000 | 4,000,000 | 2,714,245 | Jul 15, 2020, 05:00 PM |
| Lloyd Marcea Bland | Director | Jul 14, 2020 | Buy | $16.00 | 10,000 | 160,000 | 10,000 | Jul 15, 2020, 05:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Ingalls Kerry D. | Chief Operating Officer | 03/16/2022 | 11,940 |
| Mylet Johanna | Chief Financial Officer | 12/21/2021 | 9,061 |
| Spear Matthew A. | Chief Medical Officer | 12/06/2021 | 13,220 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 12/06/2021 | 12,613 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 12/02/2021 | 29,550 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 12/01/2021 | 125,806 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/30/2021 | 195,838 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/26/2021 | 185,492 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/24/2021 | 7,260 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/29/2021 | 76,209 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/23/2021 | 98,989 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/19/2021 | 82,650 |
| Ostertag Eric | Chief Executive Officer | 11/19/2021 | 9,150 |
| Ingalls Kerry D. | Chief Operating Officer | 11/17/2021 | 14,000 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/18/2021 | 511,685 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/17/2021 | 2,021,821 |
| Malin Life Sciences Holdings Ltd | 10% Owner | 11/16/2021 | 198,383 |
| Ostertag Eric | Chief Executive Officer | 11/08/2021 | 134,171 |
| Ostertag Eric | Chief Executive Officer | 10/11/2021 | 169,504 |
| Ostertag Eric | Chief Executive Officer | 10/01/2021 | 140,604 |
| Ostertag Eric | Chief Executive Officer | 09/20/2021 | 160,020 |
| Ostertag Eric | Chief Executive Officer | 09/13/2021 | 172,729 |
| Ostertag Eric | Chief Executive Officer | 09/14/2021 | 162,712 |
| Spear Matthew A. | Chief Medical Officer | 09/09/2021 | 13,220 |
| Ostertag Eric | Chief Executive Officer | 09/02/2021 | 510,925 |
| Ostertag Eric | Chief Executive Officer | 09/01/2021 | 432,721 |
| Spear Matthew A. | Chief Medical Officer | 08/20/2021 | 5,288 |
| Spear Matthew A. | Chief Medical Officer | 08/20/2021 | 35,142 |
| Ostertag Eric | Chief Executive Officer | 08/06/2021 | 1,017,013 |
| Ostertag Eric | Chief Executive Officer | 08/03/2021 | 159,289 |
| Ostertag Eric | Chief Executive Officer | 08/02/2021 | 111,682 |
| Spear Matthew A. | Chief Medical Officer | 07/28/2021 | 26,440 |
| Ostertag Eric | Chief Executive Officer | 07/02/2021 | 245,274 |
| Ostertag Eric | Chief Executive Officer | 07/01/2021 | 200,901 |
| Spear Matthew A. | Chief Medical Officer | 06/17/2021 | 6,610 |
| Spear Matthew A. | Chief Medical Officer | 06/11/2021 | 5,288 |
| Spear Matthew A. | Chief Medical Officer | 06/11/2021 | 37,747 |
| Ostertag Eric | Chief Executive Officer | 06/02/2021 | 339,621 |
| Ostertag Eric | Chief Executive Officer | 06/01/2021 | 354,680 |
| Ostertag Eric | Chief Executive Officer | 05/03/2021 | 165,117 |
| Ostertag Eric | Chief Executive Officer | 05/04/2021 | 303,722 |
| Spear Matthew A. | Chief Medical Officer | 04/23/2021 | 6,610 |
| Spear Matthew A. | Chief Medical Officer | 04/21/2021 | 5,288 |
| Spear Matthew A. | Chief Medical Officer | 04/21/2021 | 33,752 |
| Ostertag Eric | Chief Executive Officer | 04/01/2021 | 546,330 |
| Ostertag Eric | Chief Executive Officer | 04/05/2021 | 558,668 |
| Ostertag Eric | Chief Executive Officer | 03/02/2021 | 658,415 |
| Ostertag Eric | Chief Executive Officer | 03/01/2021 | 676,046 |
| Ostertag Eric | Chief Executive Officer | 02/23/2021 | 130,666 |
| Ostertag Eric | Chief Executive Officer | 02/16/2021 | 1,332,036 |
| Ostertag Eric | Chief Executive Officer | 02/10/2021 | 87,119 |
| Ostertag Eric | Chief Executive Officer | 02/10/2021 | 123,890 |
| Ostertag Eric | Chief Executive Officer | 01/21/2021 | 44,620 |
| Mylet Johanna | Senior Vice President, Finance | 01/15/2021 | 1,418 |
| Spear Matthew A. | Chief Medical Officer | 01/15/2021 | 10,000 |
| Spear Matthew A. | Chief Medical Officer | 01/08/2021 | 5,184 |
| Murphy Sean | Director | 07/14/2020 | 160,000 |
| Hirsch David | Director | 07/14/2020 | 4,000,000 |
| Lloyd Marcea Bland | Director | 07/14/2020 | 160,000 |
Load More Insider Transactions